Drug comparisons
Gliclazide vs Acarbose
Gliclazide vs Acarbose for type 2 diabetes: sulfonylurea vs alpha-glucosidase inhibitor. Compare efficacy, hypoglycemia risk, GI effects, and which may be preferable.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when choosing between a sulfonylurea and an alpha-glucosidase inhibitor as add-on therapy for type 2 diabetes.
Bottom line
Gliclazide and Acarbose have distinct mechanisms, with Gliclazide more potent for glucose lowering but Acarbose having a lower hypoglycemia risk, requiring personalized choice.
All medication comparisons